About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials | 7,495 Studies Recruiting

Clinical TrialsProstate Cancer

Prostate Cancer Clinical Trials

Browse 7,495 clinical trials for prostate cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2921-2940 of 7,495 trials

CompletedC-Acetate PET/CT Imaging to Evaluate Treatment Changes in Prostate CancerPatients with castrate resistant prostate cancer (CRPCA) with osseous metastatic disease planning to undergo Ra-223 therapy may be eligible for this study.NCT02715583·Philadelphia, Pennsylvania UnknownMitoxantrone and G-CSF in Treating Patients With Metastatic Prostate CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003183·Kansas City, Kansas and 1 other RecruitingABlative Radiotherapy (for) Unfavorable Prostate TumorsPublished clinical evidence confirms that a single dose of 24 Gy provides unprecedented long-term local control in primary and metastatic prostate cancer with safe toxicity…NCT04831983·Monza, MB

Related Searches

prostate carcinomatrials

Data from ClinicalTrials.govTerms

RecruitingGenomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)To evaluated the safety and efficacy of genomic biomarker-guided neoadjuvant therapy for locally advanced and oligometastatic prostate cancer.NCT06387056·Xiamen, Fujian

CompletedStudy Assessing The Efficacy And Safety Of Avodart (Dutasteride) At Improving Urinary Symptoms In Men With Prostate Cancer Who Are Undergoing Seed ImplantationAvodart (dutasteride) reduces the male hormone (DHT) that leads to prostate growth and stimulates cancerous growth.NCT00805701·Watertown, Massachusetts

WithdrawnDocetaxel Followed by Provenge in Metastatic Prostate CancerThis clinical study will evaluate the role of combination therapy of docetaxel followed by Provenge for patients with metastatic castration-resistant prostate cancer (CRPC…NCT02793765·Houston, Texas

CompletedA Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate CancerThe purpose of this international, phase 2, open-label, response rate study of talazoparib is to assess the efficacy and safety of talazoparib in men with DNA repair defects…NCT03148795·Tempe, Arizona and 119 others

RecruitingThe PROSECCA Study, Answering New Questions in Prostate CancerNearly half of all cancer patients receive radiotherapy as part of their treatment and although it is effective at destroying cancerous lesions deep within the body, this comes at…NCT06714630·Edinburgh, Lothian

CompletedCopper Cu 64 TP3805 PET in Detecting Cancer in Patients With Prostate Cancer Undergoing SurgeryThis pilot phase I trial studies copper Cu 64 TP3805 (Cu-64-TP3805) positron emission tomography (PET)/computed tomography (CT) in detecting cancer in patients with prostate…NCT02603965·Philadelphia, Pennsylvania

UnknownPRostate Cancer Individual Signature Evaluation Trial in Patients Undergoing Scheduled Prostate BiopsyThe purpose of this study is to develop and validate a blood-based diagnostic test that will predict prostate biopsy outcome as positive or negative for prostate cancer.NCT00966095·San Bernardino, California and 16 others

TerminatedIMU-935 in Patients With Progressive, Metastatic Castration Resistant Prostate CancerDose escalation study to evaluate the safety, tolerability and anti-tumor activity of single agent IMU-935 in patients with progressive, metastatic castration resistant prostate…NCT05124795·London

RecruitingMultiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate CancerBackground: Active surveillance (AS) is a standard approach to treat low and intermediate risk prostate cancer. For AS, disease progression is monitored.NCT04692675·Bethesda, Maryland

CompletedEvaluation of Prostate-specific Membrane Antigen (PSMA)-Based PET Imaging of Primary Prostate CancerThe objective of this study is to evaluate a radiolabeled urea-based small molecule inhibitor of prostate-specific membrane antigen (PSMA), \[18F\]DCFBC (DCFBC), as a PET imaging…NCT01496157·Baltimore, Maryland

CompletedSafety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancerwe propose to randomize patients with hormone resistant prostate cancer between docetaxel/estramustine/prednisone and docetaxel/prednisone in a phase II study.NCT00541281·Ottignies, Brabant Wallon and 18 others

WithdrawnA Study of Copanlisib in Combination with Degarelix in People with Prostate CancerThe researchers are doing this study to find out whether copanlisib in combination with degarelix, given before standard surgical treatment (radical prostatectomy), is a safe and…NCT06218667

RecruitingA Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate CancerIn this study, ASP5541 will be given to Chinese men with prostate cancer. It will be given together with prednisone and androgen deprivation therapy (ADT).NCT07339267·Beijing, Beijing Municipality

CompletedEflornithine in Treating Patients At High Risk of Developing Prostate CancerRATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer.NCT00006101·Orange, California

CompletedAlisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate CancerThis phase I/II trial studies the side effects and best dose of alisertib when given together with abiraterone acetate and prednisone and to see how well it works in treating…NCT01848067·Philadelphia, Pennsylvania

TerminatedDecreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose.Doctors leading this study plan to collect new information about the lowest effective dose of abiraterone acetate in study participants with prostate cancer who are taking…NCT05276492·Chicago, Illinois

CompletedPS-341 Followed by Removal of Prostate for Those With Prostate CancerFollowing pretreatment evaluation, patients receive PS-341 by intravenous push weekly for 4 consecutive weeks followed by a 24-72 hour rest period.NCT00425503·Houston, Texas

PreviousPage 147 of 375Next